EarningsQ3 2024 Earnings Report

Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Report

0 Followers

MX:VRTX Q3 2024 EPS Results

Actual EPS$74.38

Consensus EPS$69.25

Beat/MissBeat by +$5.13

One Year Ago EPS$69.29

Actual Revenue$47.13B

Expected Revenue$45.61B

Beat/MissBeat by +$1.52B

YoY Revenue Growth+11.86%

QuarterQ3 2024

Date11/04/2024

TimeAfter Close

Conference CallMonday, November 4, 2024

MX:VRTX Upcoming Earnings

Vertex Pharmaceuticals's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

MX:VRTX Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 09, 2026	2026 (Q3)	81.02 / -	81.516	―
Aug 03, 2026	2026 (Q2)	80.51 / 80.33	76.761	4.65% (+3.57)
May 04, 2026	2026 (Q1)	72.06 / 75.91	68.949	10.10% (+6.96)
Feb 12, 2026	2025 (Q4)	86.80 / 85.42	67.591	26.38% (+17.83)
Nov 03, 2025	2025 (Q3)	77.66 / 81.52	74.384	9.59% (+7.13)
Aug 06, 2025	2025 (Q2)	72.82 / 76.76	-217.886	135.23% (+294.65)
May 05, 2025	2025 (Q1)	73.31 / 68.95	80.837	-14.71% (-11.89)
Feb 10, 2025	2024 (Q4)	68.20 / 67.59	71.327	-5.24% (-3.74)
Nov 04, 2024	2024 (Q3)	69.25 / 74.38	69.289	7.35% (+5.09)
Aug 01, 2024	2024 (Q2)	-197.44 / -217.89	66.062	-429.82% (-283.95)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed